In CKD, what is a key consideration for medication dosing?

• A. Prescribe standard doses with close monitoring
• B. Renal dosing adjustments
• C. Discontinue all potentially nephrotoxic drugs
• D. Increase dose to maintain efficacy

Answer: (B)

In CKD, the main idea is that reduced kidney function slows drug clearance, so medicines that are excreted by the kidneys can build up in the body and cause toxicity. The best approach is to tailor dosing to the patient’s kidney function by making renal dosing adjustments—lowering the dose or extending the dosing interval based on eGFR or creatinine clearance and drug-specific guidance. This keeps drug exposure within a safe, therapeutic range as kidney function changes over time.

Think of it this way: you’re balancing efficacy with safety by respecting how well the kidneys can clear the drug. Standard doses without considering renal function risk accumulation; stopping all potentially nephrotoxic drugs isn’t always necessary or appropriate, as some can be used with adjustments or alternatives when needed. Increasing the dose is the opposite of what CKD requires, since it would raise exposure and toxicity risk.